Krystal Biotech, Inc. KRYS Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s deferred tax assets and other non-current assets?
- Krystal Biotech, Inc. (KRYS) reported deferred tax assets and other non-current assets of $300K in Q1 2026.
- How has Krystal Biotech, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Krystal Biotech, Inc.'s deferred tax assets and other non-current assets increased by 37.6% year-over-year, from $218K to $300K.
- What is the long-term trend for Krystal Biotech, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s deferred tax assets and other non-current assets has grown at a -29.2% compound annual growth rate (CAGR), from $1.61M to $287K.